novo nordisk hims hers - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Bloomberg on MSN · 22h

Novo exits Hims & Hers partnership, citing ‘deceptive marketing’ concerns

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is using “deceptive marketing” to sell copycat versions of its obesity blockbuster Wegovy.

CBS News on MSN · 1d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

CNBC on MSN · 2d

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.

16h

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

3h

Hims & Hers: Panic Sell Or Opportunistic Buy?

The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here for a full investment ...

1don MSN

Why Hims & Hers Health Stock Is Crashing Today

The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...

Zacks Investment Research on MSN5d

Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now?

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results